Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers at the University of Birmingham in England reported Sunday that nitrous oxide may prove an effective treatment for ...

LONG BEACH, CA - March 11, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...

TITUSVILLE, N.J., Nov. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA ® (lumateperone) as an adjunctive therapy ...

Nov. 30 (UPI) --Results of a new study show that patients with major depressive order who have not been helped by antidepressants could benefit from short-term use of nitrous oxide, researchers ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Background: Major depressive disorder (MDD) is a chronic and highly disabling condition. Existing pharmacotherapies produce full remission in only 30% to 40% of treated patients. Antidepressants ...

A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for larger long-term studies. Study: ...

Most gambling addicts that arrive in treatment programs are eventually diagnosed with another underlying mental health problem, or comorbidity. Gambling addiction rarely develops alone. A new ...

A 28-year-old patient presented at 12 weeks of pregnancy with symptoms of major depressive disorder. She was treated with amitriptyline 75 mg daily, and recovered well. In her third trimester, she ...